Abbott Laboratories Skids As Covid Testing Weighs On Organic GrowthInvestors Business Daily • 01/25/23
Abbott Reports Fourth-Quarter and Full-Year 2022 Results; Issues 2023 Financial OutlookPRNewsWire • 01/25/23
Abbott Under Federal Investigation Over Baby Formula—Here's How The Pharmaceutical Giant Got HereForbes • 01/21/23
ABBOTT ALERT: Bragar Eagel & Squire, P.C. is Investigating Abbott Laboratories on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmBusiness Wire • 01/20/23